Zhiwei Cheng

Title: Zhiwei Cheng: Innovator in Pyrimidine Derivatives

Introduction

Zhiwei Cheng is a prominent inventor based in Guangzhou, China. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on pyrimidine derivatives. His research focuses on enhancing drug development processes, making him a valuable asset in the biotech industry.

Latest Patents

Zhiwei Cheng holds a patent titled "Dominant salt forms of pyrimidine derivatives, and crystal forms thereof." This patent discloses sodium salts of pyrimidine derivatives along with a series of crystal forms. These crystal forms exhibit excellent druggability, including stability, fluidity, and compressibility. This innovation provides a variety of options for active pharmaceutical ingredients (APIs) that can be utilized in subsequent drug product development.

Career Highlights

Zhiwei Cheng is currently employed at Guangdong Raynovent Biotech Co., Ltd. His work at this company has allowed him to focus on the development of new pharmaceutical compounds that can significantly impact drug efficacy and safety.

Collaborations

Zhiwei collaborates with notable colleagues, including Xiaoxin Chen and Chengwu Liu. Their combined expertise contributes to the advancement of research and development in the field of biotechnology.

Conclusion

Zhiwei Cheng's innovative work in pyrimidine derivatives and his contributions to drug development highlight his importance in the biotech sector. His patent and collaborations reflect a commitment to advancing pharmaceutical science.